Merck (MRK) Research & Development (2016 - 2025)
Historic Research & Development for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $4.2 billion.
- Merck's Research & Development fell 2777.21% to $4.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $16.5 billion, marking a year-over-year decrease of 2825.81%. This contributed to the annual value of $17.9 billion for FY2024, which is 4124.66% down from last year.
- Latest data reveals that Merck reported Research & Development of $4.2 billion as of Q3 2025, which was down 2777.21% from $4.0 billion recorded in Q2 2025.
- In the past 5 years, Merck's Research & Development registered a high of $13.3 billion during Q2 2023, and its lowest value of $2.4 billion during Q1 2021.
- Over the past 5 years, Merck's median Research & Development value was $4.0 billion (recorded in 2024), while the average stood at $4.5 billion.
- In the last 5 years, Merck's Research & Development skyrocketed by 37609.01% in 2023 and then tumbled by 7372.57% in 2024.
- Quarter analysis of 5 years shows Merck's Research & Development stood at $3.1 billion in 2021, then rose by 23.04% to $3.8 billion in 2022, then surged by 155.02% to $9.6 billion in 2023, then crashed by 52.38% to $4.6 billion in 2024, then decreased by 7.64% to $4.2 billion in 2025.
- Its Research & Development was $4.2 billion in Q3 2025, compared to $4.0 billion in Q2 2025 and $3.6 billion in Q1 2025.